Average Co-Inventor Count = 5.30
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Epigenomics Ag (14 from 68 patents)
2. Roche Diagnostics Gmbh (480 patents)
3. F. Hoffmann-la Roche Ag (168 patents)
4. Signature Diagnostics Ag (0 patent)
14 patents:
1. 11186879 - Methods and nucleic acids for analyses of cellular proliferative disorders
2. 10731215 - Method for determining the presence or absence of methylation in a sample
3. 10385402 - Methods and nucleic acids for analyses of cellular proliferative disorders
4. 9850532 - Methods and nucleic acids for the analysis of gene expression associated with the development of prostate cell proliferative disorders
5. 9695478 - Methods and nucleic acids for the analyses of cellular proliferative disorders
6. 9605306 - Methods and nucleic acids for the analysis of gene expression associated with the development of prostate cell proliferative disorders
7. 9017944 - Methods for the prognosis of breast cancer
8. 8900829 - Methods and nucleic acids for analyses of cellular proliferative disorders
9. 8623599 - Method for methylation analysis
10. 8101359 - Method for determining risk of relapse of breast cancer following tamoxifen adjuvant therapy
11. 7972784 - Method for quantification of methylated DNA
12. 7951563 - Methods and nucleic acids for analysis of cellular proliferative disorders
13. 7749702 - Methods and nucleic acids for the analyses of cellular proliferative disorders
14. 7381808 - Method and nucleic acids for the differentiation of prostate tumors